CrushSCI.com
193.3Average days
175.5Median days
87Fastest days
367Longest days
832025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

133 days

An Early Value Assessment of Biomarker-Guided Precision Medicine for Treatment-Resistant Hypertension: A Headroom and Threshold Analysis

Authors
Teebah Abu-Zahra; Sabine Grimm; Mirre Scholte; Ana I. Casas; Peter Saliba-Gustafsson; Paolo Parini; Manuela JooreShow moreShow less
Affiliations
1. Department of Clinical Epidemiology & Medical Technology Assessment (KEMTA), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands; 2. Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; 3. Departments of Medical Imaging and IQ health, Radboudumc, Nijmegen, The Netherlands; 4. Department of Neurology and Center for Translational Neuro- and Behavioural Sciences (C-TNBS), Clinic for Neurology, University Hospital Essen, Essen, Germany; 5. Cardio Metabolic Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 6. Medicine Unit of Endocrinology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden; 7. Cardio Metabolic Unit, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, SwedenShow moreShow less
Source PDF DOI Publisher page
283 days

A Practical Framework for Understanding Cost-Effectiveness and Decision Risk in Health Benefits Package Design

Authors
Cassandra Nemzoff; Sabine Grimm; Manuela Joore; Andres Madriz-Montero; Stella Matutina Umuhoza; James Humuza; Sedona Sweeney; Rob Baltussen; Anna VassallShow moreShow less
Affiliations
1. Department of Global Health, London School of Hygiene and Tropical Medicine, London, UK; 2. Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre+, Maastricht, Netherlands; 3. Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands; 4. School of Public Health, University of Rwanda, Kigali, Rwanda; 5. Radboud University Medical Center, Nijmegen, NetherlandsShow moreShow less
Source PDF DOI Publisher page
151 days

Spillover Effects of Medical Innovations: A Universal and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time

Authors
Rebecca Grün; Diego Hernandez; Adnan Atitallah; Platon Peristeris; Lena Steinbeck; Eva Levi,; Malina MüllerShow moreShow less
Affiliations
1. Department of Health Economics, WifOR Institute, Darmstadt, Germany; 2. Department of Health Economics, WifOR Institute, Athens, Greece; 3. Die Senatorin für Gesundheit, Frauen und Verbraucherschutz Bremen, Bremen, GermanyShow moreShow less
Source PDF DOI Publisher page
172 days

Estimating the Share of Social Surplus Generated by Pharmaceutical Innovation Accruing to Manufacturers: A Systematic Literature Review

Authors
Robert J. Nordyke; Tyler D. Wagner; Janine Ross; Sreeranjani Menon; Jonathan D. CampbellShow moreShow less
Affiliations
1. Beta6 Consulting, Topanga, United States; 2. National Pharmaceutical Council, Washington, USA; 3. Petauri Evidence, York, England; 4. Massachusetts College of Pharmacy and Health Sciences, Boston, USAShow moreShow less
Source PDF DOI Publisher page
198 days

Evaluating Mongolia’s Sugar-Sweetened Beverage Tax: A Cost-Effectiveness Analysis

Authors
Nyamdavaa Byambadorj; Rohan Best; Undram Mandakh; Kompal SinhaShow moreShow less
Affiliations
1. Department of Economics, Macquarie Business School, Macquarie University, Sydney, Australia; 2. Department of Family Medicine, School of Medicine, Mongolian National University of Medical Science, Ulaanbaatar, MongoliaShow moreShow less
Source PDF DOI Publisher page
149 days

Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile

Authors
Yuna Lim; Gerardo Chowell; Eunok JungShow moreShow less
Affiliations
1. Department of Mathematics, Konkuk University, Seoul, Republic of Korea; 2. Department of Population Health Sciences, Georgia State University, Atlanta, USA; 3. Department of Applied Mathematics, Kyung Hee University, Yongin, Republic of KoreaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Applied Health Economics and Health Policy take to review a manuscript?

As of 2026-11-18, CrushSCI has 20 complete review records for Applied Health Economics and Health Policy. The fastest paper went from submission to acceptance in 87 days (Cost Effectiveness of Endovascular Thrombectomy for Large Ischemic Strokes: A US Healthcare Payer Markov Model Informed by Randomized Trials, received 2026-01-03, accepted 2026-03-31); the slowest took 367 days. The average is 193.3 days and the median is 175.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.